AbbVie and Tentarix Announce Collaboration to Develop Conditionally-Active, Multi-Specific Biologics for Oncology and Immunology

AbbVie Inc. and Tentarix Biotherapeutics today announced a multi-year collaboration focused on the discovery and development of conditionally-active, multi-specific biologic candidates in oncology and immunology. The collaboration will integrate AbbVie’s expertise in oncology and immunology with Tentarix’s proprietary Tentacles™ platform. Tentacles™ are multi-functional, conditionally-active antibody-based biologics that are designed specifically to activate immune cells that […]

Viatris Receives Global Minimized Risk of Antimicrobial Resistance Certification, Advancing its Commitment to Responsible Antibiotic Production

Viatris Inc. a global healthcare company, announced that its Aurangabad, India, facility has received certification from the British Standards Institution (BSI) for meeting a new industry standard on Minimized Risk of Antimicrobial Resistance (AMR). The standard was facilitated by BSI for the AMR Industry Alliance, an organization made up of over 100 companies and associations […]

Researchers led by University College Dublin could save tens of thousands of lives with new pre-eclampsia diagnosis

A team led by University College Dublin (UCD) has been working on an innovative research initiative that could transform pre-eclampsia diagnosis. It is designed to support clinicians to make effective and efficient clinical diagnosis of suspected pre-eclampsia through intelligent and timely risk stratification of patients’ clinical and blood biomarker data, using technology from SAS, the […]

PharmaLinea’s UTI Free Sachets clinically shown to improve standard antibiotic therapy and resolve the crucial issue of recurrence

In light of the upcoming International Women’s Day, PharmaLinea has announced the publication of a new clinical study, addressing one of the most pressing global health issues for women – recurring urinary tract infections (UTIs). UTIs are highly prevalent and highly persistent. Standard antibiotic treatment, while efficient at clearing the infection, often fails to prevent […]

Cresset Announces Global Collaboration with Enamine on New Virtual Screening Drug Discovery Technology

Cresset, an innovative provider of integrated in silico solutions for drug discovery announces a collaboration with Enamine, the world’s leading provider of chemical building blocks and drug discovery services to develop innovative new solutions for the early drug discovery process. The newly announced collaboration involves the development of groundbreaking technology to enable the screening of […]

Why Tissue Paper Is The Smart Choice For A Sustainable World

COMMITTED TO SUSTAINABILITY ACROSS THE SUPPLY CHAIN ETS is committed to driving sustainable practices throughout the industry. It is also looking to increase sustainability across the supply chain– from water and energy through to transport and recovery. Tissue paper production ensures that every part of the raw material – trees – is put to good […]

Drug Discovery Gets A Novel Approach With Biology-Driven AI

The quite hectic journey so as to bring a single new drug to the market essentially spans a decade as well as costs an average of $2.6 billion. The AI as well as computing revolutions, however, happen to be dynamically changing the pharma sector, thereby ushering in a new era when it comes to drug […]

Clinical Trial Automation Advent Fuels Sustainable Pharma

The pharmaceutical sector is looking for certain transformative strategies so as to stay ahead in an era that is marked by fast technological growth as well as increasing stress when it comes to environmental consciousness. This endeavor has led to the discovery of automation as a major tool in terms of redefining the clinical trial […]

Cancer Diagnostics Market Outlook 2031: Growth Trends and Insights

The global cancer diagnostics market, valued at USD 163.7 billion in 2021, is anticipated to witness substantial growth, reaching over USD 335.7 billion by 2031, with a projected compound annual growth rate (CAGR) of 7.4% from 2022 to 2031. Analysts foresee several factors contributing to this growth trajectory, including technological advancements, government initiatives, and increased funding […]

Patient-Centred Approach Creating Space In Pharmaceuticals

Apparently, pharmaceutical industry happens to be going through a prominent shift towards patient-centric approaches, thereby recognizing the significance of considering patient perspectives right across drug development as well as the healthcare delivery process. This shift happens to be driven by the desire to elevate treatment outcomes, enhance patient experiences, as well as align healthcare solutions […]